(Q38482161)

3 September 2017

1 reference

title

Interval breast cancers are not biologically distinct--just more difficult to diagnose (English)

1 reference

3 September 2017

Koivunen D

1

1 reference

3 September 2017

Zhang X

2

1 reference

3 September 2017

Blackwell C

3

1 reference

3 September 2017

Adelstein E

4

1 reference

3 September 2017

Humphrey L

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

The American Journal of Surgery

3 September 2017

published in

1 reference

3 September 2017

volume

168

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

538-542

1 reference

Screening for breast cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Risk for breast cancer development determined by mammographic parenchymal pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

CA-15.3, TPA and MCA as markers for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

The impact of breast cancer screening on survival. A 5- to 10-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Survival experience in the Breast Cancer Detection Demonstration Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

A prospective study of mammographic parenchymal patterns and risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

Mammographic breast pattern and the risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980118-7

10.1016/S0002-9610(05)80118-7

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference